supp.fit

Vitamin B6: study protocols

269 study groups say how much Vitamin B6 participants took a day. These are the doses the studies gave. They are not a recommendation.

Vitamin B6: what the research found →

Dose per serving from products

25,111 products in our catalogue print how much Vitamin B6 a serving holds.

Most common: 1 mg to 2.5 mg, 32% of 25,111 products.

Dose per servingProducts
500 mcg or less
1,123
500 mcg to 1 mg
2,100
1 mg to 2.5 mg
7,975
2.5 mg to 5 mg
4,223
5 mg to 10 mg
3,628
10 mg to 25 mg
2,993
25 mg to 50 mg
1,866
over 50 mg
1,203

Dose per serving from research

267 study groups in 207 studies say how much Vitamin B6 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg, 36% of 267 study groups.

Daily doseStudy groups
500 mcg or less
5
500 mcg to 1 mg
12
1 mg to 2.5 mg
18
2.5 mg to 5 mg
25
5 mg to 10 mg
20
10 mg to 25 mg
36
25 mg to 50 mg
96
50 mg to 100 mg
31
100 mg to 250 mg
14
over 250 mg
10

Commonly used together

189 of 269 study groups took Vitamin B6 with something else. Shown: what 3 or more different studies gave. The 10 most common of 21.

What was given together, not what works together.

Taken withStudy groups
Vitamin B12
151
Folic Acid
135
Riboflavin
22
Thiamine
22
Vitamin C
13
Vitamin D
13
Vitamin E
13
Zinc
12
Calcium
10
Vitamin B9
10

269 study groups

Study
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa
2017 · enhanced prophylaxis · Adults and children aged 5 years or older with HIV infection, CD4+ count below 100 cells/mm³, and no previous ART
25 mg12 weeks906
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial
2008 · vitamin B6 alone · Adults undergoing coronary angiography with coronary artery disease or aortic valve stenosis
40 mg165 weeks772
Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial
2017 · pyridoxine arm · Patients with breast, colorectal, or other cancers scheduled to receive single-agent capecitabine chemotherapy
200 mg—105
Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study
2022 · Pyridoxine group · Adults aged 40–76 with newly diagnosed or relapsed/refractory multiple myeloma receiving PLD-based chemotherapy
200 mg7 days52
Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia
2010 · 200 mg pyridoxine group · Patients with histologically confirmed breast or colorectal cancer receiving single-agent capecitabine
200 mg—28
High-dose Vitamin-B6 reduces sensory over-responsivity
2024 · Vitamin-B6 · Adults aged 18–60 from a general population sample; the analysed high-SOR subgroup had high baseline sensory over-responsivity scores.
100 mg40 days113
A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study
2000 · 50 mg vitamin B6 · Women with mild premenstrual symptoms, average age 32 years
50 mg—44
Comparison of quince with vitamin B6 for treatment of nausea and vomiting in pregnancy: a randomised clinical trial
2017 · vitamin B6 group · Pregnant women at 6–14 weeks’ gestation with mild-to-moderate nausea and vomiting
60 mg7 days36
Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study
1991 · vitamin B6 group · Pregnant women with nausea and vomiting of pregnancy; age and other demographic details not reported
75 mg3 days31
A comparison between the effects of ginger, pyridoxine (vitamin B6) and placebo for the treatment of the first trimester nausea and vomiting of pregnancy (NVP)
2018 · B6 group · Pregnant women at 6–16 weeks of pregnancy with mild to moderate nausea and vomiting of pregnancy
80 mg4 days26
Role of bromocriptine and pyridoxine in premenstrual tension syndrome
2007 · pyridoxine group · Women aged 20–45 with premenstrual syndrome
100 mg90 days20
Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high-flux haemodialysis and human recombinant erythropoietin
2000 · Vitamin B(6) · Patients with chronic renal failure on high-flux haemodialysis and human recombinant erythropoietin who had peripheral polyneuropathy
60 mg4 weeks14
Pyridoxine improves endothelial function in cardiac transplant recipients
2001 · pyridoxine · Cardiac transplant recipients; age and sex not specified
100 mg10 weeks11
Vitamin B6 Supplementation Reduces Symptoms of Depression in College Women Taking Oral Contraceptives: A Randomized, Double-Blind Crossover Trial
2023 · vitamin B6 · Healthy college women aged 18–25 using oral contraceptives consistently for at least 1 year
100 mg4 weeks8
Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages
2002 · vitamin B-6 · healthy younger, middle-aged and older women
75 mg5 weeks—
A randomized controlled trial of ginger to treat nausea and vomiting in pregnancy
2004 · vitamin B6 group · Pregnant women less than 16 weeks pregnant
75 mg3 weeks—
Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus
2006 · Vitamin B6 · Children with type 1 diabetes mellitus; age and sex not specified
100 mg8 weeks—
Comparison of the effectiveness of ginger and vitamin B6 for treatment of nausea and vomiting in early pregnancy: a randomized double-blind controlled trial
2007 · vitamin B6 · Pregnant women at gestational age 16 weeks or less with nausea and vomiting
75 mg4 days—
A Pilot Randomized Treatment-Controlled Trial Comparing Vitamin B6 with Broad-Spectrum Micronutrients for Premenstrual Syndrome
2020 · vitamin B6 · regularly menstruating women with premenstrual syndrome (PMS)
80 mg——
High-dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression
2022 · Vitamin B6 group · Adults aged 18–58 years, mainly young students; no diagnosed condition specified
100 mg5 weeks—
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
2010 · B vitamins · Patients with recent stroke or transient ischaemic attack within the past 7 months
25 mg1241 days4,089
Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial
2012 · B vitamins · Patients with recent stroke or transient ischemic attack
25 mg1241 days4,082
Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial
2012 · B-vitamins group · Adults with a stroke or transient ischaemic attack within the previous 7 months; men and women, age not restricted
25 mg1241 days4,040
Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial
2008 · Active treatment · Women aged 40 years or older with a history of cardiovascular disease or at least three cardiovascular risk factors
50 mg2665 days2,721
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study
2009 · folic acid/B6/B12 group · Women at high risk of cardiovascular disease, with preexisting cardiovascular disease or at least three coronary risk factors; women included in these AMD analyses had no AMD diagnosis at baseline.
50 mg2665 days2,607
Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial
2009 · Active treatment · Women aged 45 years or older at high risk for cardiovascular disease, without diabetes at baseline
50 mg2665 days2,132
Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women
2016 · combination treatment group · Women with preexisting cardiovascular disease or at least three coronary risk factors; ages 40 and older
50 mg2665 days1,969
B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial
2014 · vitamins · Community-dwelling adults aged 50 years or over with DSM-IV-TR major depression
25 mg52 weeks77
Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia
2010 · 400 mg pyridoxine group · Patients with histologically confirmed breast or colorectal cancer receiving single-agent capecitabine
400 mg—28
Homocysteine lowering with folic acid and B vitamins in vascular disease
2006 · active-treatment group · Patients aged 55 years or older with vascular disease or diabetes
50 mg5 years—
Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study
2007 · MC-1 250 mg · High-risk patients scheduled for coronary artery bypass graft surgery with cardiopulmonary bypass
250 mg30 days—
Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study
2007 · MC-1 750 mg · High-risk patients scheduled for coronary artery bypass graft surgery with cardiopulmonary bypass
750 mg30 days—
Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial
2008 · combined folic acid/vitamin B6/vitamin B12 treatment · Women aged 40 years or older with a history of cardiovascular disease or at least three coronary risk factors
50 mg2666 days—
Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial
2009 · vitamin therapy group · Adults with known cardiovascular disease
50 mg5 years—
B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial
2010 · B-vitamins · Stroke survivors; age and sex not specified
25 mg383 days—
Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study
2009 · Group DB (combination therapy) · Adults with acute lumbago
100 mg7 days187
Can vitamin B6 alleviate the adverse reactions of quadruple anti-Helicobacter pylori regimen? : randomized controlled trial
2023 · vitamin B6 supplement treatment group · Men and women aged 18–75 with Helicobacter pylori infection
40 mg2 weeks130
A randomized comparison of ginger and vitamin B6 in the treatment of nausea and vomiting of pregnancy
2003 · vitamin B6 group · Pregnant women at or before 16 weeks of gestation with nausea and vomiting of pregnancy
30 mg3 days64
A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study
2000 · 200 mg Mg + 50 mg vitamin B6 · Women with mild premenstrual symptoms, average age 32 years
50 mg—44
Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double-blind placebo-controlled trial
2023 · 25 mg PM · Abdominally obese adults; 54% female, mean age 50 years
25 mg8 weeks36
Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double-blind placebo-controlled trial
2023 · 200 mg PM · Abdominally obese adults; 54% female, mean age 50 years
200 mg8 weeks36
Comparing ginger and vitamin B6 for the treatment of nausea and vomiting in pregnancy: a randomised controlled trial
2009 · vitamin B6 group · Pregnant women at or before 17 weeks’ gestation with nausea
40 mg4 days34
Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: a randomized controlled clinical trial
2022 · Vitamin B6 intervention · People aged 15–50 with restless legs syndrome, excluding those with specified risk factors; sex not restricted
40 mg60 days25
Alcoholic abstinence syndrome: short-term treatment with metadoxine
1991 · control group · Inpatients with chronic alcoholism presenting a mild withdrawal syndrome
40 mg10 days20
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12
2011 · Vitamin B6, without folic acid and vitamin B12 · Adults with stable coronary artery disease; mean age 57.8 years; sex not specified
40 mg2 years—
Efficacy of vitamins B1 and B6 as an adjunctive therapy to lithium in bipolar-I disorder: A double-blind, randomized, placebo-controlled, clinical trial
2024 · vitamin B6 · Hospitalized patients with bipolar-I disorder in a manic episode; age and sex not reported
40 mg8 weeks—
Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial
1995 · pyridoxine hydrochloride · Pregnant women at 17 weeks' gestation or earlier with nausea and vomiting of pregnancy
30 mg5 days—
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial
2008 · folic acid plus vitamin B12 plus vitamin B6 · Adults undergoing coronary angiography with coronary artery disease or aortic valve stenosis
40 mg165 weeks772
Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial
2002 · homocysteine-lowering therapy · Patients with coronary artery disease after successful percutaneous coronary intervention; age and sex not specified
10 mg26 weeks272
Effectiveness of homocysteine lowering vitamins in prevention of thrombotic tendency at high altitude area: A randomized field trial
2015 · intervention · Indian soldiers freshly inducted to a high-altitude area
3 mg2 years—
Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis
2013 · B-vitamins · Patients with previous stroke or transient ischemic attack who were cognitively unimpaired at the cognitive assessment
25 mg1241 days1,110
Effect of magnesium and vitamin B6 supplementation on mental health and quality of life in stressed healthy adults: Post-hoc analysis of a randomised controlled trial
2021 · Magnesium + vitamin B6 · Adults aged 18–50 with moderate to extremely severe stress and suboptimal serum magnesium levels
30 mg8 weeks132
A Randomized Control Trial of Dexketoprofen/Vitamin B (Thiamine, Pyridoxine and Cyanocobalamin) Fixed-Dose Combination in Post-Traumatic Grade I-II Cervical Sprains
2024 · Dexketoprofen/vitamin B · Adults aged 18 years or older, both sexes, with grade I–II post-traumatic cervical sprain and acute pain
150 mg7 days83
Pyridoxine supplementation for levetiracetam-related neuropsychiatric adverse events in pediatric and adolescent epilepsy: a prospective, double-blind, randomized, placebo-controlled trial
2025 · pyridoxine · Children and adolescents aged 1–18 years, both sexes, with epilepsy and levetiracetam-related neuropsychiatric adverse events
10 mg/kg8 weeks51
The efficiency of cabergoline vs pyridoxine for lactation inhibition-a randomized controlled trial
2024 · pyridoxine · Postpartum patients who requested lactation inhibition and had no disease contraindicating cabergoline
600 mg7 days43
Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort
1992 · Vitamin B-6 supplementation · Healthy, self-supporting men aged 70–79 years
20 mg90 days38
Vitamin B₆ supplementation in pregnant women with nausea and vomiting
2012 · Group 1 (10 mg pyridoxine hydrochloride) · Pregnant women before the 12th gestational week experiencing nausea and/or vomiting
10 mg2 weeks30
Vitamin B₆ supplementation in pregnant women with nausea and vomiting
2012 · Group 2 (1.28 mg pyridoxine hydrochloride) · Pregnant women before the 12th gestational week experiencing nausea and/or vomiting
1.28 mg2 weeks30
Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study
2006 · vitamin B(6) group · Inpatients with schizophrenia or schizoaffective disorder and acute neuroleptic-induced akathisia
1.2 g5 days23
[Vitamin B6 add-on therapy in treatment of schizophrenic patients with psychotic symptoms and movement disorders]
2003 · vitamin B6 · Patients with schizophrenia or schizoaffective disorder, positive psychotic symptoms, and tardive dyskinesia
400 mg9 weeks15
Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study
2004 · vitamin B6 · Inpatients with schizophrenia or schizoaffective disorder and acute neuroleptic-induced akathisia
600 mg5 days10
Effects of a leucine and pyridoxine-containing nutraceutical on fat oxidation, and oxidative and inflammatory stress in overweight and obese subjects
2012 · NuFit active blend · Overweight or obese men and women aged 29 ± 4.5 years
30 mg4 weeks10
Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study
2007 · vitamin B(6) · Patients with schizophrenia or schizoaffective disorder and tardive dyskinesia; age not reported
1.2 g12 weeks—
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease
2008 · B vitamin group · Women aged 65 years or older with cardiovascular disease or at least three coronary risk factors; female health professionals
50 mg2411 days—
Efficacy and tolerability of advanced glycation end-products inhibitor in osteoarthritis: a randomized, double-blind, placebo-controlled study
2013 · AGEs inhibitor (drug) group · Adults with primary osteoarthritis meeting American College of Rheumatology classification criteria; mean age 57.26 years; 26 women and 4 men in the study overall
150 mg24 weeks—
Effects of Vitamin B6 (Pyridoxine) and a B Complex Preparation on Dreaming and Sleep
2018 · vitamin B6 group · Participants from across Australia; age, sex, and health condition not specified
240 mg5 days—
Megadose vitamins in bladder cancer: a double-blind clinical trial
1994 · megadose vitamins arm · Patients with biopsy-confirmed transitional cell carcinoma of the bladder receiving BCG immunotherapy
100 mg—35
Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren
2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified
1.7 mg335 days—
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
2.2 mg——
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension
2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women
25 mg——
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension
2005 · Multivitamin without vitamin A · HIV-positive pregnant Tanzanian women
25 mg——
Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis
2013 · AGE-S · Subjects evaluated for coronary artery calcium; age, sex, and specific condition are not stated
12.5 mg1 year—
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study
2009 · vitamin group · Adults aged 21 years or older with advanced chronic kidney disease or end-stage renal disease and high plasma homocysteine
100 mg1128 days339
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial
2009 · B-vitamin group · Men and postmenopausal women aged 40 years or older with fasting total homocysteine ≥8.5 μmol/L and no clinical signs or symptoms of cardiovascular disease
50 mg1132 days254
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial
2008 · high-dose supplement group · Adults over 50 with mild to moderate probable Alzheimer disease and normal vitamin B12 and folate levels
25 mg548 days240
[Results of a double-blind study of diclofenac + vitamin B1, B6, B12 versus diclofenac in patients with acute pain of the lumbar vertebrae. A multicenter study]
1990 · Diclofenac plus vitamins B1, B6, and B12 · Patients with acute pain of the lumbar vertebrae; age and sex not specified
300 mg2 weeks184
Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial
2008 · treatment with vitamins · Men aged 75 years and older, free of clinically significant depression at baseline
25 mg2 years150
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial
2012 · B-vitamin group · Adults aged 70 years or older with mild cognitive impairment
20 mg2 years133
Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: A randomized, single-blind clinical trial
2018 · Mg–vitamin B6 combination · Adults aged 18–50 with moderate to extremely severe stress and suboptimal serum magnesium concentrations
15 mg8 weeks132
Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy
1997 · Group A · Adults with diabetes and symptomatic peripheral neuropathy
50 mg4 weeks100
Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy
1997 · Group B · Adults with diabetes and symptomatic peripheral neuropathy
1 mg4 weeks100
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
2010 · Active treatment group · Adults aged 70 years or older with mild cognitive impairment
20 mg2 years85
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial
2000 · treatment group · Healthy siblings of patients with premature atherothrombotic disease
250 mg2 years78
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease
2012 · combined therapy · Patients with cardiovascular disease at high cardiovascular risk; age and sex not reported
10 mg6 weeks36
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease
2012 · group V · Patients with cardiovascular disease at high cardiovascular risk; age and sex not reported
10 mg6 weeks18
Use of Nutritional Supplements Based on L-Theanine and Vitamin B6 in Children with Tourette Syndrome, with Anxiety Disorders: A Pilot Study
2022 · THE-group · Children aged 4–17 years with Tourette syndrome or chronic tic disorder and anxiety symptoms
2.8 mg60 days17
Short-Term Effects of Folate Supplementation in Combination With Vitamin B6 for Treating Acute Manic Episodes in Bipolar I Disorder: A Randomized Controlled Trial
2025 · Folate/vitamin B6 group · Adults aged 18–45 with bipolar I disorder in an acute manic episode
80 mg6 weeks14
Brief communication. Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunction
1992 · active vitamin group · Geriatric inpatients with depression and cognitive dysfunction
10 mg4 weeks—
Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study
2005 · Vitamin therapy · Community-dwelling elderly adults, median age 76 years; both sexes; vitamin deficiencies were present in a subset
3 mg120 days—
Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus
2006 · Folate/vitamin B6 · Children with type 1 diabetes mellitus; age and sex not specified
100 mg8 weeks—
Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet
2009 · B vitamin supplementation · Adults aged 45–64 years with longstanding coeliac disease, on a strict gluten-free diet for several years
3 mg26 weeks—
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12
2011 · Folic acid and vitamin B12 plus vitamin B6 · Adults with stable coronary artery disease; mean age 57.8 years; sex not specified
40 mg2 years—
B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial
2014 · B vitamins only · Adults aged 45–80 with a recent history of myocardial infarction, unstable angina, or ischemic stroke
3 mg1716 days—
The effects of folic acid and pyridoxine supplementation on characteristics of migraine attacks in migraine patients with aura: A double-blind, randomized placebo-controlled, clinical trial
2017 · folic acid plus pyridoxine · Adults aged 18–65 with migraine with aura
80 mg90 days—
B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial
2017 · treatment group (high-dose vitamin group) · Men and women aged 35–75 with stable kidney function for at least 6 months after kidney transplantation and elevated plasma homocysteine
50 mg2008 days—
[Dry jelly concentrate with vitamins and dietary fiber in patients with IBS with constipation: a comparative controlled study]
2015 · Dry jelly concentrate group · Patients with IBS with constipation (IBS-C) meeting Rome III criteria; age and sex not reported
3.6 mg2 weeks—
The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B(12), B(6), and Folic Acid on Symptoms and Neurocognition in First-Episode Psychosis
2019 · B-vitamin supplement group · Patients with first-episode psychosis; age and sex not specified
50 mg12 weeks—
The Weight Loss Effects of Branched Chain Amino Acids and Vitamin B6: A Randomized Controlled Trial on Obese and Overweight Women
2018 · BCAA with vitamin B6 · Overweight and obese women (BMI 25–34.9 kg/m²)
40 mg4 weeks—
Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis
2005 · B6 group · Adults over 18 with rheumatoid arthritis and plasma pyridoxal 5'-phosphate in the lowest age- and sex-matched quartile
50 mg30 days14
Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial
2025 · intervention group · Chinese adults with mild cognitive impairment; mean age 67.95 years; 70 male and 120 female
960 mcg1 year95
Effect of zinc plus multivitamin supplementation on growth in school children
2016 · Chelated zinc plus multivitamins · Healthy Thai schoolchildren aged 4–13 years
1 mg26 weeks70
Investigating the Effects of a Multinutrient Supplement on Cognition, Mood and Biochemical Markers in Middle-Aged Adults with 'Optimal' and 'Sub-Optimal' Diets: A Randomized Double Blind Placebo Controlled Trial
2022 · active supplementation · Adults aged 40–65 years, healthy and without neurological, cognitive, mood or psychiatric disorders; participants had either an optimal or sub-optimal diet
41.1 mg12 weeks70
Effect of a Combination of Magnesium, B Vitamins, Rhodiola, and Green Tea (L-Theanine) on Chronically Stressed Healthy Individuals-A Randomized, Placebo-Controlled Study
2022 · Mg-Teadiola · Adults aged 18–65, either sex, otherwise healthy and chronically stressed (DASS-42 stress score ≥14)
700 mcg4 weeks51
Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients
2007 · mecobalamin (B12) + multivitamin supplement · Taiwanese men and women aged over 50 with mild to moderate Alzheimer's disease and normal folic acid and vitamin B12 concentrations
5 mg26 weeks45
L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation
2018 · Nutritional intervention group · Men and postmenopausal women aged 40–65 with slightly to moderately elevated blood pressure
3 mg26 weeks40
L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation
2018 · Placebo group receiving open-label TAP in follow-up · Men and postmenopausal women aged 40–65 with slightly to moderately elevated blood pressure
3 mg13 weeks40
Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
2024 · 10-element combination tablet · Overweight or obese adults with type 2 diabetes and mild-to-moderate painful diabetic neuropathy; mean age 63 years
3 mg26 weeks36
A functional evaluation of anti-fatigue and exercise performance improvement following vitamin B complex supplementation in healthy humans, a randomized double-blind trial
2023 · Ex PLUS® group · Healthy male and female non-athletes aged 20–30
50 mg4 weeks32
Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
2023 · active treatment · Adult women with ME/CFS, aged 18 years or older
1.05 mg36 weeks29
Improved cycling time-trial performance after ingestion of a caffeine energy drink
2009 · Red Bull Energy Drink · Trained male and female cyclists; mean age 27.3 years
10 mg1 day12
Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation
2011 · Group MVB · Patients with type 2 diabetes
10 mg120 days—
B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial
2014 · B vitamins plus n-3 fatty acids · Adults aged 45–80 with a recent history of myocardial infarction, unstable angina, or ischemic stroke
3 mg1716 days—
Three-month B vitamin supplementation in pre-school children affects folate status and homocysteine, but not cognitive performance
2014 · B vitamin supplementation group · Healthy preschool children selected for low urinary folate-status ranking
730 mcg90 days—
Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly
2015 · treatment group · Healthy adults aged 60–74 years
2 mg1 year—
Vitamin B-6 Supplementation Could Mediate Antioxidant Capacity by Reducing Plasma Homocysteine Concentration in Patients with Hepatocellular Carcinoma after Tumor Resection
2016 · vitamin B-6 50 mg/d group · Adults aged 30–79 with hepatocellular carcinoma who had undergone tumor resection
50 mg12 weeks17
Impact of Glutathione and Vitamin B-6 in Cirrhosis Patients: A Randomized Controlled Trial and Follow-Up Study
2020 · vitamin B-6 group · Adults aged 20–80 with diagnosed liver cirrhosis
50 mg12 weeks14
Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease
2004 · 50 mg vitamin B(6) · Patients with coronary artery disease and at least 70% stenosis of one major coronary artery
50 mg12 weeks9
Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial
1997 · vitamin B6 · Clinically stable renal transplant recipients
50 mg—7
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour
2002 · Vitamin B6 alone · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women
50 mg12 weeks—
Effect of lysine, vitamin B(6), and carnitine supplementation on the lipid profile of male patients with hypertriglyceridemia: a 12-week, open-label, randomized, placebo-controlled trial
2012 · vitamin B(6) group · Adult Lebanese men with hypertriglyceridemia, approximately 50 years old
50 mg12 weeks—
Lowering homocysteine with B vitamins has no effect on blood pressure in older adults
2007 · Vitamins group · Healthy adults aged 65 years or older with homocysteine concentrations of at least 13 micromol/L
10 mg2 years—
Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: a randomized placebo-controlled study
2003 · Group C · Patients aged 38–80 years undergoing coronary angiography
40 mg12 weeks—
A 2-Year Randomized Controlled Trial With Low-Dose B-Vitamin Supplementation Shows Benefits on Bone Mineral Density in Adults With Lower B12 Status
2022 · B-vitamin treatment · Community-dwelling adults aged 50 years or older; men and women; no specific diagnosed condition, and not currently taking B-vitamin supplements at screening
10 mg2 years103
Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial
2009 · AGE+S · Intermediate-risk adults, mean age 60 ± 9 years; 79% male
12.5 mg1 year—
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease
2022 · Vitamin B6 · Adults with suspected coronary artery disease undergoing angiography for stable angina; mean age 61.2 years, 71.5% male
40 mg1387 days52
Comparative Study to Evaluate the Effect of Low-Protein Diet Supplementation with Taurine and N-Acetylcysteine, N-Acetylcysteine and Pyridoxamine Dihydrochloride in Preventing the Progression of Chronic Renal Failure in Patients with Non-Diabetic Kidney Disease
2022 · NP (NAC + pyridoxamine dihydrochloride) arm · Adults with non-diabetic chronic renal failure, GFR >15 and <60 ml/min/1.73 m², receiving standard care
100 mg26 weeks24
Effect of Folic Acid, Betaine, Vitamin B₆, and Vitamin B12 on Homocysteine and Dimethylglycine Levels in Middle-Aged Men Drinking White Wine
2016 · Vitamin B6 group · Healthy men aged 37–65 years who were moderate alcohol consumers
40 mg4 weeks22
Impact of Glutathione and Vitamin B-6 in Cirrhosis Patients: A Randomized Controlled Trial and Follow-Up Study
2020 · B-6 + GSH group · Adults aged 20–80 with diagnosed liver cirrhosis
50 mg12 weeks15
Folic acid supplement decreases the homocysteine increasing effect of filtered coffee. A randomised placebo-controlled study
2003 · pyridoxine group · Healthy, nonsmoking men and women aged 29–65 years
40 mg4 weeks—
Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention
2004 · group C · Patients with suspected coronary artery disease; age and sex not stated
40 mg90 days—
Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease
2005 · vitamin B-6 · Adults aged 65 years or older with ischemic vascular disease
25 mg1 year—
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease
2007 · C: vitamin B6 alone · Adults aged 38–80 with suspected coronary artery disease
40 mg26 weeks—
Effect of lysine, vitamin B(6), and carnitine supplementation on the lipid profile of male patients with hypertriglyceridemia: a 12-week, open-label, randomized, placebo-controlled trial
2012 · lysine plus vitamin B(6) group · Adult Lebanese men with hypertriglyceridemia, approximately 50 years old
50 mg12 weeks—
The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine
2013 · Vitamin B6 alone · Adults with suspected or established coronary artery disease who underwent coronary angiography; median age 60 years
40 mg316 days—
Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial
2019 · vitamin B6 · Adults with suspected coronary artery disease who underwent coronary angiography; mean age about 61 years, 69.8% male
40 mg165 weeks—
Effect of Combined Treatment With Folic Acid, Vitamin B(6), and Vitamin B(12) on Plasma Biomarkers of Inflammation and Endothelial Dysfunction in Women
2018 · Folic Acid/B6/B12 · Adult women at increased cardiovascular risk, with pre-existing cardiovascular disease or at least three coronary risk factors
50 mg2665 days150
Impact of magnesium supplementation, in combination with vitamin B6, on stress and magnesium status: secondary data from a randomized controlled trial
2020 · Magnesium-vitamin B6 · Adults with stress; the erythrocyte-magnesium subgroup analysis included participants with low baseline erythrocyte magnesium (<1.6 mmol/L).
30 mg8 weeks132
Prospective Randomized Evaluation of Idiopathic Hyperoxaluria Treatments
2021 · low oxalate diet and supplementation (DS) · Patients with a documented history of calcium oxalate stones and newly diagnosed idiopathic hyperoxaluria
25 mg12 weeks55
Prospective Randomized Evaluation of Idiopathic Hyperoxaluria Treatments
2021 · supplementation (S) · Patients with a documented history of calcium oxalate stones and newly diagnosed idiopathic hyperoxaluria
25 mg12 weeks47
Vitamin B-6 status indicators decrease in women consuming a diet high in pyridoxine glucoside
1996 · High PNG diet · Women; age and health condition not specified
1.52 mg18 days9
Vitamin B-6 status indicators decrease in women consuming a diet high in pyridoxine glucoside
1996 · Low PNG diet · Women; age and health condition not specified
1.44 mg18 days9
Vitamin B-6 requirement and status assessment: young women fed a depletion diet followed by a plant- or animal-protein diet with graded amounts of vitamin B-6
1995 · Depletion diet · Eight healthy young women
50 mcg4 weeks8
Vitamin B-6 requirement and status assessment: young women fed a depletion diet followed by a plant- or animal-protein diet with graded amounts of vitamin B-6
1995 · Animal-protein diet, 0.5 mg vitamin B-6 · Eight healthy young women
500 mcg3 weeks8
Vitamin B-6 requirement and status assessment: young women fed a depletion diet followed by a plant- or animal-protein diet with graded amounts of vitamin B-6
1995 · Animal-protein diet, 1.0 mg vitamin B-6 · Eight healthy young women
1 mg3 weeks8
Vitamin B-6 requirement and status assessment: young women fed a depletion diet followed by a plant- or animal-protein diet with graded amounts of vitamin B-6
1995 · Animal-protein diet, 1.5 mg vitamin B-6 · Eight healthy young women
1.5 mg3 weeks8
Vitamin B-6 requirement and status assessment: young women fed a depletion diet followed by a plant- or animal-protein diet with graded amounts of vitamin B-6
1995 · Animal-protein diet, 2.0 mg vitamin B-6 · Eight healthy young women
2 mg3 weeks8
Vitamin B-6 requirement and status assessment: young women fed a depletion diet followed by a plant- or animal-protein diet with graded amounts of vitamin B-6
1995 · Plant-protein diet, 0.5 mg vitamin B-6 · Eight healthy young women
500 mcg3 weeks8
Vitamin B-6 requirement and status assessment: young women fed a depletion diet followed by a plant- or animal-protein diet with graded amounts of vitamin B-6
1995 · Plant-protein diet, 1.0 mg vitamin B-6 · Eight healthy young women
1 mg3 weeks8
Vitamin B-6 requirement and status assessment: young women fed a depletion diet followed by a plant- or animal-protein diet with graded amounts of vitamin B-6
1995 · Plant-protein diet, 1.5 mg vitamin B-6 · Eight healthy young women
1.5 mg3 weeks8
Vitamin B-6 requirement and status assessment: young women fed a depletion diet followed by a plant- or animal-protein diet with graded amounts of vitamin B-6
1995 · Plant-protein diet, 2.0 mg vitamin B-6 · Eight healthy young women
2 mg3 weeks8
A longitudinal study of pyridoxine and zinc supplementation of lactating women
1990 · 0.5 mg pyridoxine, 0 mg zinc · Lactating women beginning 1 day postpartum
500 mcg39 weeks—
A longitudinal study of pyridoxine and zinc supplementation of lactating women
1990 · 4.0 mg pyridoxine, 0 mg zinc · Lactating women beginning 1 day postpartum
4 mg39 weeks—
Plasma AGE-peptides and C-peptide in early-stage diabetic nephropathy patients on thiamine and pyridoxine therapy
2013 · B6 · Adults with type 2 diabetes and diabetic nephropathy
250 mg150 days12
Effect of oral pyridoxine hydrochloride supplementation on in vitro platelet sensitivity to different agonists
1995 · vitamin B6 group · Healthy men aged 19–24 years
5 mg/kg4 weeks12
Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease
2004 · 5 mg vitamin B(6) · Patients with coronary artery disease and at least 70% stenosis of one major coronary artery
5 mg12 weeks8
Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease
2004 · 10 mg vitamin B(6) · Patients with coronary artery disease and at least 70% stenosis of one major coronary artery
10 mg12 weeks8
Preoperative oral B vitamins prevent nitrous oxide-induced postoperative plasma homocysteine increases
2001 · Vitamin group · Patients undergoing elective revision knee or hip arthroplasty, scheduled for surgery lasting longer than 3 hours
25 mg7 days—
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial
2005 · vitamin therapy · Patients with recent transient ischemic attack or stroke; age and sex not reported
25 mg26 weeks—
Sustained homocysteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population
2005 · active VITATOPS medication · Patients with stroke or transient ischemic attack
25 mg26 weeks—
Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, Vitamins B6 and B12
2005 · treatment group · Adults aged 60 ± 8 years with carotid intima-media thickness ≥1 mm and at risk of cerebral ischemia
25 mg1 year—
Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial
2009 · B-vitamin therapy · Adults with a history of ischemic stroke
25 mg1461 days—
Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial
2010 · B-vitamin group · People with type 1 or type 2 diabetes and a clinical diagnosis of diabetic nephropathy
25 mg3 years—
Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy
2013 · supplement group · Patients with diabetic nephropathy; age and sex not reported
80 mg12 weeks—
The Effects of the AGE Inhibitor Pyridoxamine on Bone in Older Women With Type 2 Diabetes: A Randomized Clinical Trial
2025 · Pyridoxamine (PM) · Older women with type 2 diabetes
400 mg1 year—
Vitamin requirements for the treatment of hyperhomocysteinemia in humans
1994 · vitamin B-6 · men with hyperhomocysteinemia
10 mg6 weeks—
Folic acid causes higher prevalence of detectable unmetabolized folic acid in serum than B-complex: a randomized trial
2016 · B-complex · Elderly people
8 mg23 days27
Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid
2002 · Folic acid group · Adults with chronic stable hemodialysis and hyperhomocysteinemia
50 mg12 weeks24
Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid
2002 · Folinic acid group · Adults with chronic stable hemodialysis and hyperhomocysteinemia
50 mg12 weeks22
Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study
2002 · Vitamin B(12), folic acid, and vitamin B(6) · Patients aged 38–80 years undergoing coronary angiography
40 mg12 weeks—
Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: a randomized placebo-controlled study
2003 · Group A · Patients aged 38–80 years undergoing coronary angiography
40 mg12 weeks—
Concentrations of unmetabolized folic acid and primary folate forms in plasma after folic acid treatment in older adults
2011 · folic acid treatment group · Older adults, median age 82 years; sex and health condition not specified
40 mg3 weeks—
A longitudinal study of pyridoxine and zinc supplementation of lactating women
1990 · 0.5 mg pyridoxine, 25 mg zinc · Lactating women beginning 1 day postpartum
500 mcg39 weeks—
A longitudinal study of pyridoxine and zinc supplementation of lactating women
1990 · 4.0 mg pyridoxine, 25 mg zinc · Lactating women beginning 1 day postpartum
4 mg39 weeks—
One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans
2015 · B-vitamin supplementation · Older German adults, mean age 67 years
50 mg1 year—
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception
2.6 mg—870
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication.
1 mg24 weeks501
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2.
1 mg24 weeks201
Lowering plasma homocysteine concentrations of older men and women with folate, vitamin B-12, and vitamin B-6 does not affect the proportion of (n-3) long chain polyunsaturated fatty acids in plasma phosphatidylcholine
2008 · vitamin group · Men and women aged 65 years or older with plasma homocysteine concentrations of at least 13 micromol/L
10 mg2 years127
Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment
2021 · B-vitamin group · Men and women, mean age 77.6 years, with mild cognitive impairment
20 mg2 years95
Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial
2015 · high-dose B vitamin supplementation · Adults aged 70 years or older with mild cognitive impairment
20 mg2 years85
The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis
2008 · Vitamins · People with a history of stroke or transient ischemic attack; age range and sex not restricted
25 mg4 years83
Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial
2003 · Folic acid plus vitamin B6 treatment · Healthy adults who were siblings of patients with premature atherosclerotic disease
250 mg2 years78
Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial
2004 · vitamin-treated group · Healthy siblings of patients with premature atherosclerotic disease; mean age 46.0 years; sex not specified
250 mg2 years78
Supplementation with antioxidant micronutrients in pregnant women with obesity: a randomized controlled trial
2024 · Intervention group · Pregnant women with obesity (BMI ≥30 kg/m²)
18 mg—64
Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study
2018 · VMP (Nutrilite Double X™) · Generally healthy adults aged 40–70 years in Moscow with low habitual recommended-food intake (recommended food score <12), predominantly women; no chronic diseases
3 mg8 weeks60
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease
2022 · Folic acid + vitamins B12, B6 · Adults with suspected coronary artery disease undergoing angiography for stable angina; mean age 61.2 years, 71.5% male
40 mg1387 days52
Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure
2002 · Folic acid and pyridoxine without glycine betaine · Patients with chronic renal failure who were folate and pyridoxine replete
50 mg90 days36
Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure
2002 · Folic acid, pyridoxine, and glycine betaine · Patients with chronic renal failure who were folate and pyridoxine replete
50 mg90 days36
Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance
2005 · All patients receiving vitamin therapy · Haemodialysis patients with end-stage renal disease; age and sex not reported
25 mg24 weeks35
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial]
2005 · Supraphysiological daily-dose regimen · Adults with stable maintenance hemodialysis (mean age 68 years; 48% male)
100 mg1 year33
A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels
2019 · Natural vitamin B complex (group N) · Healthy adults; age range and sex not specified
3.38 mg6 weeks30
A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels
2019 · Synthetic vitamin B complex (group S) · Healthy adults; age range and sex not specified
3.38 mg6 weeks30
Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation
2005 · open therapy with vitamins · Adults with ischemic heart disease and plasma homocysteine at least 15.0 micromol/L
40 mg90 days29
The impact of folate status and folic acid supplementation on the micronucleus frequency in human erythrocytes
2006 · folic acid, vitamin B12 and vitamin B6 supplementation group · Both-sex participants without folate deficiency; age not reported
4 mg7 days29
Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients
2003 · group A · Adults with hyperhomocysteinemia who were stable renal-transplant recipients
50 mg26 weeks28
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial]
2005 · Daily renal multivitamin regimen · Adults with stable maintenance hemodialysis (mean age 68 years; 48% male)
10 mg1 year27
Effect of Methylfolate, Pyridoxal-5'-Phosphate, and Methylcobalamin (Soloways(TM)) Supplementation on Homocysteine and Low-Density Lipoprotein Cholesterol Levels in Patients with Methylenetetrahydrofolate Reductase, Methionine Synthase, and Methionine Synthase Reductase Polymorphisms: A Randomized Controlled Trial
2024 · methylfolate, P5P, and methylcobalamin · Adults aged 40–75 with elevated homocysteine, LDL-C of 70–190 mg/dL, and at least one minor allele in a specified MTHFR, MTR, or MTRR polymorphism
100 mg180 days27
Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients
2004 · Group A · Hemodialysis patients with hyperhomocysteinemia; age and sex not reported
25 mg—26
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2000 · FA group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
50 mg12 weeks25
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2000 · MTHF group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
50 mg12 weeks25
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · MTHF group · Adults with chronic, stable hyperhomocysteinemia receiving maintenance hemodialysis
50 mg12 weeks25
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Folic acid group · Adults with chronic, stable hyperhomocysteinemia receiving maintenance hemodialysis
50 mg12 weeks25
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2001 · L-folinic acid group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
50 mg12 weeks24
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2001 · Folic acid group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
50 mg12 weeks24
Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients
2004 · Group B · Hemodialysis patients with hyperhomocysteinemia; age and sex not reported
100 mg—24
B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke
2004 · B-group vitamin supplements · Patients with acute ischaemic stroke, enrolled within 12 hours of symptom onset; age and sex not specified
50 mg2 weeks24
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
50 mg2 weeks24
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
50 mg2 weeks24
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 1 · Chronic, stable renal transplant recipients; age and sex not stated
50 mg12 weeks20
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 2 · Chronic, stable renal transplant recipients; age and sex not stated
50 mg12 weeks20
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 3 · Chronic, stable renal transplant recipients; age and sex not stated
50 mg12 weeks20
Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial
2005 · group 2 · Women with polycystic ovarian syndrome treated with metformin; age not reported
500 mg90 days20
Vitamin B(6) supplementation improves pro-inflammatory responses in patients with rheumatoid arthritis
2010 · vitamin B(6) · Patients with rheumatoid arthritis
100 mg12 weeks20
Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation
2002 · vitamin supplementation · Male volunteers aged 40 years or younger; nine matched pairs received vitamins, including hyperhomocysteinemic and normohomocysteinemic subjects
2 mg8 weeks18
[Treatment of hyperhomocysteinemia and endothelial dysfunction in renal-transplant recipients with vitamin B]
2005 · vitamin treatment (group A) · Stable hyperhomocysteinemic renal-transplant recipients
50 mg26 weeks18
Fortified breakfast cereal consumed daily for 12 wk leads to a significant improvement in micronutrient intake and micronutrient status in adolescent girls: a randomised controlled trial
2016 · Fortified cereal, morning · Females aged 16–19 years who regularly skipped breakfast and had low riboflavin status and haemoglobin; no diagnosed illness
1.74 mg12 weeks18
Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial
2020 · DHA treatment arm · Cognitively unimpaired men and women aged 55 years and older with a first-degree family history of dementia
100 mg26 weeks18
Fortified breakfast cereal consumed daily for 12 wk leads to a significant improvement in micronutrient intake and micronutrient status in adolescent girls: a randomised controlled trial
2016 · Fortified cereal, evening · Females aged 16–19 years who regularly skipped breakfast and had low riboflavin status and haemoglobin; no diagnosed illness
1.74 mg12 weeks16
Plasma AGE-peptides and C-peptide in early-stage diabetic nephropathy patients on thiamine and pyridoxine therapy
2013 · B1+B6 · Adults with type 2 diabetes and diabetic nephropathy
250 mg150 days15
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Renal transplant recipients · Renal transplant recipients with hyperhomocysteinemia
50 mg12 weeks10
Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation
2002 · group III · Haemodialysis patients with chronic renal failure and hyperhomocysteinaemia
60 mg3 weeks7
Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial
1997 · vitamin B6, folic acid, and vitamin B12 · Clinically stable renal transplant recipients
50 mg—7
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Hemodialysis patients receiving folic acid · Hemodialysis patients with hyperhomocysteinemia and baseline total homocysteine comparable to the renal transplant recipients
50 mg12 weeks—
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Hemodialysis patients receiving MTHF · Hemodialysis patients with hyperhomocysteinemia and baseline total homocysteine comparable to the renal transplant recipients
50 mg12 weeks—
Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete
2001 · Vitamin B-6 supplementation group · Healthy adults aged 63–80 years; folate- and riboflavin-replete, with no vitamin B-12 deficiency
1.6 mg12 weeks—
Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate
2001 · fenofibrate plus vitamins · men with hyperlipidemia
5 mg6 weeks—
Effect of homocysteine reduction by B-vitamin supplementation on markers of clotting activation
2002 · high-dose B-vitamin supplements · Healthy volunteers with homocysteine >16 μmol/L or ≤16 μmol/L
50 mg8 weeks—
Reduction of plasma homocysteine and serum methylmalonate concentrations in apparently healthy elderly subjects after treatment with folic acid, vitamin B12 and vitamin B6: a randomised trial
2003 · B-vitamin treatment · Community-dwelling apparently healthy adults aged 70–93 years; median age 76 years
3 mg120 days—
Mineral water fortified with folic acid, vitamins B6, B12, D and calcium improves folate status and decreases plasma homocysteine concentration in men and women
2004 · Fortified mineral water · Free-living men and women without folate deficiency or elevated homocysteine
1 mg8 weeks—
Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial
2004 · Fortified cereal group · Volunteers aged 50–85 years without the listed medical conditions who did not regularly use multiple or B-vitamin supplements or highly fortified breakfast cereal
1.8 mg12 weeks—
The effect of homocysteine reduction by B-vitamin supplementation on markers of endothelial dysfunction
2004 · B-vitamins · Healthy volunteers, including hyperhomocysteinemic and normohomocysteinemic participants
50 mg8 weeks—
Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia
2006 · Vitamin group · Community-dwelling men aged 75 years or older
25 mg2 years—
No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk
2006 · Study I: B vitamins · Siblings of patients with clinical atherosclerotic disease and postmethionine hyperhomocysteinaemia; ages and sex not stated
250 mg1 year—
Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients
2006 · Treatment group · Chronic hemodialysis patients with hyperhomocysteinemia; age and sex not specified
50 mg26 weeks—
Effect of fortified spread on homocysteine concentration in apparently healthy volunteers
2007 · spread 1 · Apparently healthy adult volunteers; 50% male; age range not reported
1 mg6 weeks—
Effect of fortified spread on homocysteine concentration in apparently healthy volunteers
2007 · spread 2 · Apparently healthy adult volunteers; 50% male; age range not reported
1 mg6 weeks—
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease
2007 · A: folic acid/vitamin B12/vitamin B6 · Adults aged 38–80 with suspected coronary artery disease
40 mg26 weeks—
Treatment of hyperhomocysteinemia and endothelial dysfunction in renal transplant recipients with B vitamins in the Chinese population
2008 · folate treatment · Chinese renal transplant recipients with hyperhomocysteinemia; age and sex not reported
50 mg26 weeks—
Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients
2008 · group 1 · Adults with diabetes treated with high-dose metformin
10 mg120 days—
Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: Implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy
2008 · oral vitamin treatment · Community-dwelling adults, mean age 76 years
3 mg120 days—
The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability
2009 · vitamin supplementation · patients diagnosed with migraine with aura; age and sex not reported
25 mg26 weeks—
Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations
2010 · vitamins group · Healthy adults aged 65 years or older with elevated homocysteine (>13 micromol/l)
10 mg2 years—
Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment
2013 · B-vitamin treatment · Elderly adults with mild cognitive impairment and increased dementia risk
20 mg2 years—
The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine
2013 · Folic acid plus vitamin B12 plus vitamin B6 · Adults with suspected or established coronary artery disease who underwent coronary angiography; median age 60 years
40 mg316 days—
MTHFR 677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial
2018 · Group A: B-vitamins · Adults with a history of cardiovascular disease, including men and women; mean age 61.3 years
3 mg1716 days—
Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial
2019 · folic acid + vitamin B12 + vitamin B6 · Adults with suspected coronary artery disease who underwent coronary angiography; mean age about 61 years, 69.8% male
40 mg165 weeks—
Vitamin requirements for the treatment of hyperhomocysteinemia in humans
1994 · combination of folic acid, vitamin B-12 and vitamin B-6 · men with hyperhomocysteinemia
10 mg6 weeks—
Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
1993 · daily vitamin supplement · Apparently healthy men with moderate hyperhomocysteinemia
10 mg6 weeks—
Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers
1998 · high-dose multivitamin supplements · Patients with a history of recurrent venous thrombosis and hyperhomocysteinemic healthy volunteers
50 mg——
Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women
2021 · test group · Premenopausal Indian women aged 25–45 years in good general health, with BMI 18–30 kg/m²
2 mg180 days57
Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial
2016 · Normocis 400® group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male
3 mg60 days52
Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD
2009 · Treatment group · Adults with stage 2 to 4 chronic kidney disease and creatinine clearance of 15 to 70 mL/min/1.73 m²
100 mg2 years47
Effects of low-dose B vitamins plus betaine supplementation on lowering homocysteine concentrations among Chinese adults with hyperhomocysteinemia: a randomized, double-blind, controlled preliminary clinical trial
2023 · supplement group · Chinese adults aged 18–65 with hyperhomocysteinemia (blood homocysteine 15–100 μmol/L)
8 mg12 weeks44
Effect of adding B-vitamins to vitamin D and calcium supplementation on CpG methylation of epigenetic aging markers
2018 · D + Ca + B · Adults, mean age 68.4 years; no specific condition stated
50 mg1 year32
Plasma trimethylamine-N-oxide following supplementation with vitamin D or D plus B vitamins
2017 · vitamin D + B arm · Participants; age, sex, and health condition not specified
50 mg1 year25
Cardiovascular disease-risk factors in middle-aged osteopaenic women treated with calcium alone or combined to three nutrients essential to artery and bone collagen
2008 · group C · Middle-aged women with low bone mineral density (osteopaenia)
75 mg1 year20
Metabolic consequences of discretionary fortified beverage consumption containing excessive vitamin B levels in adolescents
2019 · fortified beverage (FB) · Healthy adolescents aged 13–19 years, male and female
40 mg1 day20
High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients
1996 · Supraphysiologic-dose B-vitamin supplementation · Hyperhomocysteinemic dialysis patients
100 mg8 weeks15
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour
2002 · Folic acid, riboflavin, and vitamin B12 with vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women
50 mg12 weeks—
Folate therapy and in-stent restenosis after coronary stenting
2004 · folate group · Patients who had undergone successful coronary stenting
48 mg26 weeks—
Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention
2004 · group A · Patients with suspected coronary artery disease; age and sex not stated
40 mg90 days—
One year B and D vitamins supplementation improves metabolic bone markers
2013 · group A · Healthy adults older than 54 years
50 mg1 year—
Co-administration of methyl donors along with guanidinoacetic acid reduces the incidence of hyperhomocysteinaemia compared with guanidinoacetic acid administration alone
2013 · GAA with methyl donors group · Healthy male and female volunteers
10 mg8 weeks—
Effects of mixed dietary supplements on total plasma homocysteine concentrations (tHcy): a randomized, double-blind, placebo-controlled trial
2012 · supplement group · hospitalized, acutely ill older patients recovering from acute illness; sex and age range not stated
1.4 mg6 weeks—
One-carbon metabolites and telomere length in a prospective and randomized study of B- and/or D-vitamin supplementation
2017 · group A · Adults older than 54 years; no specific condition stated
50 mg1 year—
MTHFR 677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial
2018 · Group C: B-vitamins and n-3 fatty acids · Adults with a history of cardiovascular disease, including men and women; mean age 61.3 years
3 mg1716 days—
Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study
2002 · Vitamin B(6) · Patients aged 38–80 years undergoing coronary angiography
40 mg12 weeks—
Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation
2004 · folic acid, vitamin B12, and vitamin B6 group · Patients undergoing coronary angiography
40 mg1 year—
Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation
2004 · vitamin B6 alone group · Patients undergoing coronary angiography
40 mg1 year—